Sterne, Kessler, Golstein & Fox P.L.L.C.
Antibodies to notch receptors
The present invention relates to Notch-binding agents and Notch antagonists and methods of using the agents and/or antagonists for treating diseases such as cancer. The present invention provides antibodies that specifically bind to a non-ligand binding region of the extracellular domain of one or more human Notch receptor, such as Notch2 and/or Notch3, and inhibit tumor growth. The present invention further provides methods of treating cancer, the methods comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human Notch receptor protein and inhibits tumor growth.
OncoMed Pharmaceuticals, Inc.
C C A A A A C A C A C C C C C C C C C A C A C C C C C C A C C A C C
C07K C07K A61K A61N A61K A61P C07K A61P C12N A61K C07K C07K C07K C07H C07K C07K C12N C07K C07K A61P C07K A61K C07K C12N C07K C12N C07K C07K A61P C07K C07K A61K C07K C12N
additional additional inventional inventional additional inventional additional inventional additional inventional additional additional additional additional additional inventional inventional inventional inventional inventional inventional inventional additional additional additional additional additional inventional inventional additional additional inventional inventional additional
Timothy Charles Austin L. John A. Yuan Ching Aaron Ken Edward Thein Htun Maureen Fitch
Hoey Gurney Lewicki Liu Sato van der Horst Bruhns